Product
SHR-2002
1 clinical trial
1 indication
Indication
Advanced Malignant TumorsClinical trial
A Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SHR-2002 Injection in Combination With SHR-1316 in Patients With Advanced Malignant TumorsStatus: Active (not recruiting), Estimated PCD: 2025-07-01